Background: Id3 is a dominant antagonist of E protein transcription factor activity that is induced by signals emanating from the ab and cd T cell receptor (TCR). Mice lacking Id3 were previously shown to have subtle defects in positive and negative selection of TCRab + T lymphocytes. More recently, Id3 2/2 mice on a C57BL/6 background were shown to have a dramatic expansion of cd T cells.
Introduction
T lymphocytes bearing ab or cd T cell receptors (TCR) develop in the thymus from a common progenitor cell pool. Most cells in the adult thymus express the co-receptor molecules CD4 and CD8 and represent an intermediate stage in ab T cell development that has undergone productive TCRb rearrangement and is in the process of TCRa rearrangement. After expression of a functional TCRa CD4 +
CD8
+ (double positive, DP) cells undergo negative or positive selection and become single positive (SP) cells [1] . In contrast, the earliest T cell progenitors, and cd T cells, are CD4 2 CD8 2 (double negative, DN) and can be divided into four stages based on expression of CD117 (c-kit) and CD25; DN1, (c-kit
2 ), DN2 (c-kit
, DN3 (c-kit-CD25 + ) and DN4 (c-kit-CD252) [2] . DN1 and DN2 cells are the most immature T cell progenitors and are not yet fully committed to T cell differentiation [3, 4] . Rearrangement of TCR loci initiates at the DN2 stage but is most prevalent in DN3 cells [5, 6] . DN3 cells that rearrange and express TCRb undergo b-chain selection and progress to the DN4 stage before becoming DP [7] . In contrast, cells that rearrange functional Tcrg and Tcrd genes diverge from the ab pathway and become DN cd T cells [2] . The stage at which the ab and cd T cell lineages diverge remains controversial [8, 9, 10, 11, 12] .
During ontogeny, the variable gene segments of the Tcrg and Tcrd genes are rearranged in ordered waves. The first wave occurs around embryonic day 13 and includes rearrangement of Vc3 and Vd1 and is followed by rearrangement of Vc4 [13, 14] (Nomenclature according to [15] ). These receptors contain limited diversity at the junction of the V, diversity (D), and joining (J) segments [16, 17] in part because terminal deoxylnucleotidyl transferase (TdT), a polymerase that adds non-templated nucleotides, is absent from embryonic cells [18, 19] . Consequently, the first cd T cells express invariant Vc3/Vd1 or Vc4/Vd1 TCRs and home specifically to the epidermis or the epithelium of the reproductive tract and the tongue, respectively [20] . In contrast to the embryo, the adult thymus rearranges Vc1.1, Vc2 and Vc5 and generates receptors with extensive junctional diversity, creating a highly diverse cd TCR repertoire [21] . Interestingly, a subset of cd T cells with an invariant Vc1.1 + Vd6. 3 + TCR has been described that resides in the adult thymus, spleen, and liver [22] . These cd T cells develop from late embryonic precursors and expand during neonatal life [23] . Vc1.1
+

Vd6.3
+ T cells share multiple characteristics with natural killer (NK) T cells including expression of the activation markers CD44, and NK1.1, and low expression of the immature T lymphocyte marker CD24. Moreover, both NKT and Vc1.1 +
+ T cells secrete IFNc and IL4 rapidly after stimulation in vitro [24] . These findings led to the hypothesis that NKT and Vc1.1 +
+ T cells represent innate branches of the ab and cd T cell lineages, respectively [25] . The presence of an invariant receptor on these two T cell subsets is consistent with the hypothesis that the functional characteristics of these ''innate-like'' cells are determined in part via selection by endogenous ligands.
T cell development is intimately linked to activity of the E protein transcription factors E2A and HEB [26, 27, 28] . E proteins are essential at multiple stages of ab T cell development and function in lymphocyte survival, proliferation and differentiation. Importantly, induction of E protein antagonists such as Id2 and Id3 appears to be critical for b-selection and positive selection of ab T cells [29, 30, 31] . Cross-linking of CD3e (a component of the TCR signalling complex) on DN3 thymocytes induces Id3 through a MAP kinase-dependent pathway [32] . Mice lacking Id3 show mild defects in positive selection similar to those observed in mice lacking the Tec kinase Itk, which activates the MAP kinases Erk1 and Erk2 [33, 34] . MAP kinase signalling is also important for proper cd T cell development and Id3 is highly expressed in cd T cells, although published data suggest that Id3 is not essential for cd T cell development in mice expressing the KN6 (Vc2 + Vd5 + ) transgene [10] . Surprisingly however, it was reported that Id3
mice have an increased number of cd T cells and it was hypothesized that Id3 functions in DN3 cells to prevent Tcrg or Tcrd rearrangement in cells expressing a functional TCRb [35] .
Here we report that the elevated number of cd T cells in Id3 [36] , a molecular determinant of the NKT cell fate [37, 38] and their development required the Signaling lymphocyte adaptor molecule (Slam)-associated Adaptor Protein (SAP) [39] . Importantly, deletion of SAP overcomes all apparent thymic alterations in Id3 2/2 mice including the increased number of cd T cells and the reduced thymic cellularity, whereas deletion of Tcrd had no effect on thymic cellularity. These observations indicate that Id3 plays a role in preventing expansion or survival of this SAP-dependent lymphocyte. Taken together, our data demonstrate that Id3 functions to limit the development of SAP-dependent ''innate-like'' cd T cells.
Results
Development of CD4
+ and CD8 + cd T Cells in Id3 2/2 Mice
While investigating the thymic phenotype of Id3 2/2 mice we discovered that the number of cd T cells is increased by approximately 8-fold (range 3-to 15-fold) compared to Id3 +/+ mice ( Fig. 1A and B) . In contrast, the frequency of TCRb high cells was similar among Id3 +/+ and Id3 2/2 thymocytes, although the number of TCRb + cells is decreased in the absence of Id3 since Id3 2/2 mice have a 3-fold decrease in thymocytes numbers ( Fig. 1A and Fig. S1 ). Further analysis revealed that a large portion of Id3 2/2 TCRc + cells express CD4 or CD8 (Fig. 1C ).
Compared to Id3
+/+ mice, Id3 2/2 mice have an increased number of CD4 (80-fold) and CD8 (70-fold) TCRc + cells as well as DN (5.5-fold) and DP (5-fold) TCRc + cells (Fig. 1D) (Fig. 1E) . Importantly, Id3 2/2 TCRc + cells expressed significantly more mRNA for the transcription factor Sox13 than DP thymocytes indicating that these are bona fide cd T cells [40] (Fig. 1F) . In the spleen there is also a large population of TCRc + cells expressing CD4 or CD8aa that is markedly elevated compared to Id3 +/+ mice (Fig. S2) . Taken together these data indicate that Id3 limits development of cd T cells, in particular, cd T cells expressing CD4 or CD8.
Id3
2/2 cd T Cells Have an Activated or ''Innate-Like'' Phenotype
In light of our observations that Id3 2/2 cd T cells expressed CD4 and CD8, we characterized these cells for expression of multiple cell surface proteins. In the thymus, the majority of Id3 2/2 DN TCRc + cells had high expression of CD122, NK1.1 and CD44 and low expression of CD24 compared with Id3 +/+ TCRc + cells ( Fig. 2A  and B ). This phenotype is associated with activation of ab and cd T cells [41, 42, 43] . Notably, a majority of the Id3 2/2 NK1.1 + TCRc + cells expressed TCRc at low levels ( Fig. 2B) . A subset of cd T cells expressing NK1.1 with low expression of TCRcd is present in the spleen of WT mice and presumably represent activated cd T cells [42] . Similar to Id3 2/2 DN TCRcd + cells, a portion of Id3 2/2 CD4 and CD8 cd T cells had these activation markers, although the CD4 cells had lower levels of CD122 and only a small portion expressed NK1.1 (Fig. 2B) . Therefore, our data indicate that a large portion of the cd T cells in the thymus of Id3 2/2 mice have an activated phenotype. The DN, CD4 and CD8 cd T cells in the spleen of Id3 2/2 mice also have an activated phenotype (Fig. S3) .
A subset of CD122 + cd T cells, which are thought to have encountered ligand in the thymus, produce IFNc rapidly after in vitro stimulation [43] . To determine whether Id3 2/2 cd T cells represent previously activated cells we tested their ability to make IFNc after in vitro stimulation with PMA and ionomycin for 5 hours. Importantly .30% of Id3 2/2 TCRc + thymocytes produce IFNc under these conditions. In contrast only 2.5% of Id3 +/+ TCRc + thymocytes produced IFNc at this early time point (Fig 2C) . Similarly, more than 50% of Id3 2/2 splenic TCRc + cells produced IFNc (Fig S3) . Interestingly, a subset of Id3 2/2 cd T cells make both IFNc and IL-4 (Fig. S4) . Cytometric bead analysis revealed that Id3 2/2 cd T cells also make more IFNc, IL4, IL10 and IL13 than their WT counterparts after stimulation with antiTCRc (Fig. S4) . Taken together, our data demonstrate that Id3 2/2 mice develop a large population of cd T cells that show characteristics of previously activated cells.
2/2 cd T Cells with an Activated Phenotype Develop Early in Post-Natal Life
To determine when during ontogeny Id3 2/2 cd T cell numbers increase and when the activated phenotype becomes evident, we examined thymocytes from mice isolated 1 week after birth. At this stage of ontogeny, few thymocytes have left the thymus and therefore peripheral activation is unlikely to have impacted on thymocyte numbers or phenotype. Importantly, a 10-fold increase in TCRc + cells was observed in Id3 2/2 neonates and the aberrant expression of CD4 was already evident (Fig. 3A , B and C). Moreover, Id3 2/2 neonatal cd T cells had an activated phenotype similar to that observed in the adult Id3 2/2 thymus ( Fig. 3D and E ), although only a small subset of these cells were positive for NK1.1. Taken together, our data indicate that Id3 limits the development of cd T cells with an activated phenotype in neonatal mice. Our data also indicate that the activated phenotype of Id3 2/2 cd T cells likely occurs within the thymus rather than as a consequence of peripheral activation since few thymocytes have left the thymus within the first week after birth [44] .
The Majority of Id3
2/2 cd T Cells Express Vc1.1 and Vd6.3
The presence of a large population of activated cd T cells in the Id3 2/2 neonatal thymus suggests that these cells derive from cells that underwent V(D)J recombination in the late embryonic or neonatal period. To gain insight into the origin of the majority of Id3 2/2 cd T cells, we examined their TCR repertoire by staining with a panel of anti-Vc antibodies. This analysis revealed that .90% of cd T cells in the Id3 2/2 thymus express Vc1.1 (Fig. 4A,   B ). This increase in Vc1.1 usage is not at the expense of the other Vc gene segments since the total number of Vc2 + and Vc5 + cd T cells are similar to that in the WT thymus, although their frequency within the cd T cell population is reduced (Fig. 4C) .
Importantly, the majority of Vc1. + T cells lacking significant TCR diversity. In addition, these sequences lacked N nucleotide additions suggesting that the rearrangements occurred in the absence of TdT (Fig. 5A) . Analysis of Vd6-Jd1 junctions also revealed a lack of diversity with 32 of 37 in-frame sequences containing the Vd6.3 gene segment, consistent with our flow cytometry analysis (Fig. 5B) . Moreover, 21 of the 32 Vd6.3-Jd1 junctions are represented by only two sequences. In the majority of sequences the Dd2-Jd1 and Vd6-Dd2 junctions resulted in maintenance of the germline sequence and the Dd1 gene segment was not observed in these junctions (Fig. 5B) . Of the 4 unique sequences that showed diversity following the Vd6.3 gene segment at least 2 represent potential P rather than N nucleotide additions. Notably, the invariable Dd2-Jd1 junction forces a unique reading frame of the Dd2 segment (V/IGGIRA), which contributes to the CDR3 domain [47] , thus resulting in a highly invariant Vc1.1 + Vd6.3 + TCR, at least for those cells using the Vc1.1-Jc4 and Vd6-Jd1 rearrangement. The presence of a highly invariant receptor on cells with an activated phenotype suggests that the Vc1.1
+ T cells are selected by a ligand present in the thymus.
To examine the possibility that the Vc1.1
2/2 mice arise as a consequence of preferential Vc1.1 and Vd6.3 rearrangement in adult thymocytes we analyzed the Vc1.1-Jc4 and Vd6-Jd1 junctions in unselected Id3 2/2 DN3 cells. This analysis revealed that the in-frame Vc1.1-Jc4 rearrangements (8/15) contained 3 unique sequences that were distinct from those amplified from Id3 2/2 cd T cells (Fig. 5A) . In addition, only 3 of 16 Vd6-Jd1 junctions were in-frame and each of these sequences was unique with one sequence containing the Vd6B gene segment (Fig. 5B) 2/2 bone marrow hematopoietic stem and progenitor cells largely fails to reconstitute this cd T cell population (Fig. S6) . (Fig. 6D and Fig. S7) mice, does not restore thymic cellularity to WT levels (Fig. S8) . Therefore, multiple alterations in the Id3 2/2 thymus are dependent on SAP signaling. Id3 is a transcriptional repressor that prevents E proteins from binding DNA [49] . All of the E proteins are expressed in T cells; however, deletion of E2A is sufficient to restore ab T cell maturation defects in Id3 2/2 [50] . Therefore, we tested the requirement for E2A in the development of activated cd T cells in Id3 2/2 mice by generating Id3 2/2 E2A 2/2 mice. Consistent a previous study we found that E2A is required for development of normal numbers of cd T cells (Fig. 7A and B) [51] . Importantly, mice that lack both Id3 and E2A have fewer cd T cells than WT mice but more cd T cells than E2A 2/2 mice (Fig. 7A and B) . Nonetheless, the cd T cells that develop in Id3 2/2 E2A 2/2 mice fail to express CD122 and NK1.1 (Fig. 7C ) Therefore, E2A is required for the development of cd T cells with an activated phenotype in Id3 2/2 mice.
Development of Activated cd T Cells in
Discussion
In this study, we report that Id3-deficiency results in a 8-fold increase in the number of cd T cells in the thymus and that the majority of these cells likely express an invariant Vc1. Vc1.1 + Vd6.3 + T cells represent an innate branch within the cd T cell lineage [25] . Here, we demonstrate that both Id3 +/+ and Id3 2/2 Vc1.1 + Vd6.3 + cells express the transcription factor PLZF, a molecular determinant of the NKT cell fate [37] . Moreover, we find that SAP is essential for development of Id3 thymus, is indistinguishable from the Id3 +/+ or Shld1a 2/2 thymus with respect to cellularity and phenotype.
Our hypothesis that Id3 functions downstream of TCR signals to limit SAP-dependent proliferation in cd T cells is consistent with previous studies demonstrating that Id3 is a target of TCR triggered signaling in both ab and cd T cells [30, 32] . The pathway from the TCR leading to Id3 involves the MAP kinases Erk1 or Erk2, which are triggered by the Tec kinases Itk and Rlk [55] . Recently, Itk 2/2 mice were reported to have an increased number of PLZF-expressing Vc1.1 + Vd6.3 + T cells, implying that Itk may also limit development of ''innate'' cd T cells [25, 56] . Our data are consistent with the hypothesis that Id3 is an essential effector of the TCR-Itk-MAP kinase pathway that determines the consequence of signaling through the Vc1.1 + Vd6.3 + TCR. Id3 is an inhibitor of E protein DNA binding [57] . We, and others, found that deletion of E2A in Id3 2/2 mice blunted the development of activated cd T cells indicating that elevated E2A function is critical for development of these cells [35] . It should be noted that E2A is required for normal cd T cells development and affects the timing of rearrangement of specific Vc receptors [21, 51] . Therefore, loss of activated cd T cells in E2A 2/2 Id3 2/2 mice, as compared to Id3 2/2 mice, could be the result of E2A functions upstream of TCR signaling and independent of Id3. However, it seems likely that Id3 deletion leads to heightened E2A
(or E protein) activity after TCR-initiated signaling events, where E2A activity would normally be inhibited. In the case of cd T cells, elevated activity of E2A may cooperate with SAP-dependent signals to promote an outcome from TCR-mediated signaling that is not typical, for example, leading to prolonged survival or proliferation.
Our analysis of Vc1.1-Jc4 and Vd6-Jd1 sequences in Id3 2/2 cd T cells and DN3 thymocytes lead us to conclude that the majority of Vc1.1 + Vd6.3 + cells in Id3 2/2 mice develop during fetal or neonatal life. This analysis revealed that Id3 2/2 cd T cells have germline sequences at the Vc1.1-Jc4 and Dd2-Jd1 junctions, very low diversity in the Vd6.3-Dd2 junction and complete absence of the Dd1 segment. However, Vc1.1-Jc4 and Vd6-Jd1 sequences retrieved from Id3 2/2 DN3 progenitors are characterized by diverse junctions. It is possible that the Vc1.1-Jc4 and Vd6-Jd1 sequences observed in Id3 2/2 cd T cells could be generated from [25, 56] . Therefore, while Id3 appears to be largely dispensable for development of conventional cd T cells, it limits the number of PLZF-expressing SAPdependent ''innate'' cd T cells.
Materials and Methods
Ethics Statement
All animal experiments were performed in compliance with the requirements of the University of Chicago Institutional Animal Care and Use Committee
Mice
Mice were housed at The University of Chicago Animal Resource Center. Id3 2/2 and Tcrd 2/2 mice were purchased from Jackson ImmunoResearch. Sh2d1a 2/2 mice were a kind gift from C. Terhorst. Genotyping was as previously described [59, 60, 61] . All experiments were performed on mice that were 6 to 8 weeks old unless otherwise indicated.
Antibodies, Flow Cytometry and Cell Sorting
Cells were blocked with anti-FccR prior to staining with specific antibodies conjugated to biotin, FITC, PE, PE-Cy7 or APC, acquired in a FACS Canto using FACSDiva software and analyzed with FLOWjo. In all experiments viable cells were gated based on forward and side scatter profiles and dead cells were further excluded using Propidium iodide. Sorting was performed on a FACSAria. The following antibodies were purchased from BD Biosciences or eBiosciences: CD4, CD8a, CD8b, TCRb, TCRcd, NK1.1, CD122, CD44, CD24, IFNc, Vc2, Vc3, ckit, and CD25. Anti-Vc1.1 (2.11), -Vc5 (F2.67) and -Vd6.3 (9D3) were described previously [45] . For analysis of Vc1.1
+ cells a minimum of 2,000 TCRcd + cells were analyzed in each experiment.
Cytometric Bead Assay (CBA) and IFNc Assay
Phorbol 12-myristate 13-acetate (PMA) plus ionomycin treatment and intracellular staining for IFNc were described previously [44] . CBA analysis was as described in [62] .
Real-Time Quantitative (Q)PCR
RNA from TCRb + CD4 and TCRb + CD8 thymocytes was DNAase-treated and reverse-transcribed using Superscript III (Invitrogen). QPCR was performed with gene-specific primers in a iCycler (BioRad), using the iQ SYBR Green Supermix (BioRad).
A standard curve was included for each primer set. Sox13 primers: qSox13(3047)for: 59-CCCTATTTCTCTCCAGACTGT-39 and qSox13(3142)rev: 59-CTGGTTAAGTTATTCATCATTATC-39. Hprt primers were reported previously [63] .
Cloning and Sequencing
DNA was isolated from 50,000 TCRcd + or 30,000 Lin-ckit-CD25 + thymocytes as previously described [51] . Vc1.1-Jc4 and Vd6-Jd1 rearrangements were then amplified by the following primers: Vc1.1 for: 59-CCGGCAAAAAGCAAAAAAGTT-39 and Jc4 rev: 59-GCAAATATCTTGACCCATGA-39, Vd6uni for: 59-AYTCTGTAGTCTTCCAGAAATCA-39 and Jd1 rev: 59-TTGGTTCCACAGTCACTTGG-39. PCR products were ligated to pGEM-T vector (Promega). DNA from single colonies was extracted and sequenced at the University of Chicago Cancer Research Center Sequencing Facility using the T7 primer. Three independent amplifications were performed from each sample in 2 independent experiments.
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